Cinclus Pharma Holding AB (publ) (CINPHA)
Free
No email, no account, no signup.
Pulling latest news for Cinclus Pharma Holding AB (publ)…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
Nasdaq Stockholm
Type
Biotech
Sector
Pharmaceuticals for gastrointestinal diseases
Market Cap
$62M
We're already tracking Cinclus Pharma Holding AB (publ) — here are the latest events we've registered
Recent News
- On March 13, 2026, Cinclus Pharma entered into a EUR 28 million financing agreement with Claret Capital Partners to support its Phase III clinical program. The company also announced that the FDA clarified that a single pivotal study will be sufficient for US market approval. The Q1 2026 interim report is scheduled for release on May 13, 2026.
Want to know how this news affects Cinclus Pharma Holding AB (publ)? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Cinclus Pharma Holding AB (publ) will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.